Evidence map›Paper›PMID 24310722›Full record

ArticleMolecular imaging and biology2014

Radiolabeled RGD tracer kinetics annotates differential αvβ 3 integrin expression linked to cell intrinsic and vessel expression.

Israt S Alam, Timothy H Witney, Giampaolo Tomasi, Laurence Carroll, Frazer J Twyman, Quang-Dé Nguyen, Eric O Aboagye

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Binding of αMolecular imaging and biology · 2018
    Article
  2. Prospective ofContrast media & molecular imaging · 2018
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Israt S AlamComprehensive Cancer Imaging Centre, Faculty of Medicine, Imperial College London, London, W12 0NN, UK.
Timothy H Witney
Giampaolo Tomasi
Laurence Carroll
Frazer J Twyman
Quang-Dé Nguyen
Eric O Aboagye
Imperial College London · GB

Funding

Cancer Research UK 10337Cancer Research UK C2536/A10337Medical Research Council A652 0030Medical Research Council MC_U120081322
6 · The paper itself

Abstract

purposeThe purpose of this paper is to study the association between RGD binding kinetics and αvβ3 integrin receptor density in the complex tumor milieu. PROCEDURES: We assessed αvβ3 in vitro and by (68)Ga-DOTA-[c(RGDfK)]2 positron emission tomography (PET) in tumors with varying αvβ3.

resultsIntrinsic αvβ3 expression decreased in the order of M21 >>> MDA-MB-231 > M21L in cells. Tumor volume of distribution by PET, V T, was significantly higher in M21 compared to isogenic M21L tumors (0.40 ± 0.01 versus 0.25 ± 0.02; p < 0.01) despite similar microvessel density (MVD) likely due to higher αvβ3. V T for MDA-MB-231 (0.40 ± 0.04) was comparable to M21 despite lower αvβ3 but in keeping with the higher MVD, suggesting superior tracer distribution.

conclusionsThis study demonstrates that radioligand binding kinetics of PET data can be used to discriminate tumors with different αvβ3 integrin expression-a key component of the angiogenesis phenotype-in vivo.

Indexed as

Organometallic CompoundsPeptides, CyclicAnimalsBlood VesselsBlotting, WesternCell Line, TumorFemaleFlow CytometryHumansImmunohistochemistryIntegrin alphaVbeta3KineticsMice, Inbred BALB CMice, NudeNeoplasmsPlatelet Endothelial Cell Adhesion Molecule-168Ga-DOTA-cyclo(arginyl-glycyl-aspartyl-phenylalanyl-lysyl)Integrin alphaVbeta3Organometallic CompoundsPeptides, CyclicPlatelet Endothelial Cell Adhesion Molecule-1Radioactive Tracers

Identifiers

PMID24310722
OpenAlexW2471862148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.